MARKET

AMRX

AMRX

AMNEAL PHARMACEU
NYSE

Real-time Quotes | Nasdaq Last Sale

4.520
-0.120
-2.59%
Closed 17:13 07/02 EDT
OPEN
4.730
PREV CLOSE
4.640
HIGH
4.730
LOW
4.500
VOLUME
961.17K
TURNOVER
--
52 WEEK HIGH
7.28
52 WEEK LOW
2.270
MARKET CAP
1.35B
P/E (TTM)
-2.8113
1D
5D
1M
3M
1Y
5Y

Analyst Rating

Based on 11 analysts

Hold

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

Analyst Price Target

The average AMRX stock price target is 4.111 with a high estimate of 6.00 and a low estimate of 3.000.

EPS

AMRX News

More
How R&D Expenses Can Help You Pick Outperforming Stocks
Seeking Alpha - Article · 3d ago
CytoDyn Signs MOU With NIH of Mexico for Coronavirus Study
Zacks · 5d ago
Zogenix Gets FDA Nod for Dravet Syndrome Seizure Treatment
Zacks · 06/26 15:48
AMRX vs. COLL: Which Stock Should Value Investors Buy Now?
Zacks · 06/19 16:40
Jazz Pharmaceuticals (JAZZ) in Focus: Stock Moves 5.6% Higher
Zacks · 06/16 13:33
Amneal Pharmaceuticals (AMRX): Hedge Funds Never Been Less Bullish
The latest 13F reporting period has come and gone, and Insider Monkey is again at the forefront when it comes to making use of this gold mine of data. Insider Monkey finished processing 821 13F filings submitted by hedge funds and prominent investors. These fi
Insider Monkey · 06/15 01:33
Moving Average Crossover Alert: Amneal Pharmaceuticals
Zacks · 06/12 13:49
States go after generic drugmakers for alleged price fixing
Seeking Alpha - Article · 06/10 15:39

Industry

Pharmaceuticals
+0.58%
Pharmaceuticals & Medical Research
+0.61%

Hot Stocks

Symbol
Price
%Change

About AMRX

Amneal Pharmaceuticals, Inc. is a specialty pharmaceutical company. The Company is engaged in the development, manufacture and marketing of bioequivalent pharmaceutical products (generics), in addition to the development and marketing of branded products. It operates in two segments, which include Generics and Specialty Pharma. The Generics is focused on the development, manufacture, sale and distribution of the Company's generic products, which are the pharmaceutical and therapeutic equivalents of brand-name drug products and are marketed under their drug names. The Specialty Pharma is engaged in the promotion, sale and distribution of several branded products, including its branded pharmaceutical product, Rytary, an extended release oral capsule formulation of carbidopa-levodopa for the treatment of Parkinson's disease (PD), post-encephalitic Parkinsonism and Parkinsonism, and Zomig (zolmitriptan) products, indicated for the treatment of migraine headaches.
More

Webull offers kinds of Amneal Pharmaceuticals Inc stock information, including NYSE:AMRX real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, AMRX stock news, and many more online research tools to help you make informed decisions.

You can practice and explore trading AMRX stock methods without spending real money on the virtual paper trading platform.